natgillin/translations-raw huggingface dataset:
Three tubes each containing 0.5 ml (60 mg selamectin).
3 tube, vsaka vsebuje 0, 5 ml (60 mg selamektina).
Six tubes each containing 0.5 ml (60 mg selamectin).
6 tub, vsaka vsebuje 0, 5 ml (60 mg selamektina).
Dogs weighing 5.1 – 10.0 kg.
Psi s telesno maso 5, 1 – 10, 0 kg.
EU/ 2/ 99/ 014/ 004 (3 tubes) EU/ 2/ 99/ 014/ 009 (6 tubes)
EU/ 2/ 99/ 014/ 004 (3 tube) EU/ 2/ 99/ 014/ 009 (6 tube)
25 PARTICULARS TO APPEAR ON THE OUTER PACKAGE
24 PODATKI NA ZUNANJI OVOJNINI
CARTON LABEL, 120 mg (ALL PACK SIZES)
Škatla, 120 mg (VSA PAKIRANJA)
STRONGHOLD 120 mg spot-on solution
STRONGHOLD 120 mg raztopina kožnih kapljic
Selamectin 120 mg
selamektin 120 mg
Three tubes each containing 1.0 ml (120 mg selamectin).
3 tube, vsaka vsebuje 1, 0 ml (120 mg selamektina).
Six tubes each containing 1.0 ml (120 mg selamectin).
6 tub, vsaka vsebuje 1, 0 ml (120 mg selamektina).
Dogs weighing 10.1 – 20.0 kg.
Psi s telesno maso 10, 1 – 20, 0 kg.
EU/ 2/ 99/ 014/ 005 (3 tubes) EU/ 2/ 99/ 014/ 010 (6 tubes)
EU/ 2/ 99/ 014/ 005 (3 tube) EU/ 2/ 99/ 014/ 010 (6 tube)
28 PARTICULARS TO APPEAR ON THE OUTER PACKAGE
27 PODATKI NA ZUNANJI OVOJNINI
CARTON LABEL, 240 mg (ALL PACK SIZES)
Škatla, 240 mg (VSA PAKIRANJA)
STRONGHOLD 240 mg spot-on solution
STRONGHOLD 240 mg raztopina kožnih kapljic
Selamectin 240 mg
selamektin 240 mg
Three tubes each containing 2.0 ml (240 mg selamectin).
3 tube, vsaka vsebuje 2, 0 ml (240 mg selamektina).
Six tubes each containing 2.0 ml (240 mg selamectin).
6 tub, vsaka vsebuje 2, 0 ml (240 mg selamektina).
Dogs weighing 20.1 – 40.0 kg.
Psi s telesno maso 20, 1 – 40, 0 kg.
EU/ 2/ 99/ 014/ 006 (3 tubes) EU/ 2/ 99/ 014/ 011 (6 tubes)
EU/ 2/ 99/ 014/ 006 (3 tube) EU/ 2/ 99/ 014/ 011 (6 tube)
FOIL LABEL, 15 mg (ALL PACK SIZES)
Tuba, 15 mg (VSA PAKIRANJA)
15 mg selamectin
15 mg selamektina
Topical spot-on solution
raztopina kožnih kapljic – nanos na kožo.
THE WORDS “ FOR ANIMAL TREATMENT ONLY”
BESEDILO “ SAMO ZA ZDRAVLJENJE ŽIVALI ”
FOIL LABEL, 30 mg (ALL PACK SIZES)
Tuba, 30 mg (VSA PAKIRANJA)
30 mg selamectin
30 mg selamektina
Topical spot-on solution
raztopina kožnih kapljic – nanos na kožo
FOIL LABEL, 45 mg (ALL PACK SIZES)
Tuba, 45 mg (VSA PAKIRANJA)
45 mg selamectin
45 mg selamektina
FOIL LABEL, 60 mg (ALL PACK SIZES)
Tuba, 60 mg (VSA PAKIRANJA)
60 mg selamectin
60 mg selamektina
FOIL LABEL, 120 mg (ALL PACK SIZES)
Tuba, 120 mg (VSA PAKIRANJA)
120 mg selamectin
120 mg selamektina
FOIL LABEL, 240 mg (ALL PACK SIZES)
Tuba, 240 mg (VSA PAKIRANJA)
PACKAGE LEAFLET
37 NAVODILO ZA UPORABO STRONGHOLD® raztopina kožnih kapljic
Manufacturer responsible for batch release:
Izdelovalec, odgovoren za sprostitev serije:
STRONGHOLD 240 mg spot-on solution
STRONGHOLD 15 mg raztopina kožnih kapljic STRONGHOLD 30 mg raztopina kožnih kapljic STRONGHOLD 45 mg raztopina kožnih kapljic STRONGHOLD 60 mg raztopina kožnih kapljic STRONGHOLD 120 mg raztopina kožnih kapljic STRONGHOLD 240 mg raztopina kožnih kapljic
STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENT(S)
NAVEDBA UČINKOVIN( E) IN DRUGE( IH) SESTAVIN( E)
Each unit dose (tube) of STRONGHOLD delivers
Enkraten odmerek (tuba) zdravila STRONGHOLD vsebuje:
Treatment and prevention of flea infestations caused by Ctenocephalides spp. for one month following a single administration.
▪ Zdravljenje in preprečevanje infestacij z bolhami, ki jih povzročajo vrste Ctenocephalides spp. - zdravilo deluje en mesec po enkratnem odmerku.
Prevention of heartworm disease caused by Dirofilaria immitis with monthly administration.
38 ▪ preprečevanje obolenj zaradi infestacij z mikrofilarijami, razvojno obliko Dirofilarie immitis, z mesečnim nanosom.
STRONGHOLD may be safely administered to animals infected with adult heartworms, however, it is recommended, in accordance with good veterinary practice, that all animals 6 months of age or more living in countries where a vector exists should be tested for existing adult heartworm infections before beginning medication with STRONGHOLD.
Kljub temu se priporoča (v skladu z dobro veterinarsko prakso), da vse živali, stare 6 mesecev in več, ki živijo v državah, kjer obstaja prenašalec mikrofilarij, pred pričetkom zatiranja s Strongholdom, testiramo na prisotnost infestacije z odraslimi oblikami Dirofilarie immitis.
Treatment of ear mites (Otodectes cynotis).
▪ zatiranje ušesnih garij (Otodectes cynotis).
Treatment of biting lice infestations (Felicola subrostratus) Treatment of adult roundworms (Toxocara cati) Treatment of adult intestinal hookworms (Ancylostoma tubaeforme).
Mačke: ▪ zatiranje infestacij z ušmi (Felicola subrostratus) ▪ zatiranje odraslih nematodov (Toxocara cati) ▪ zatiranje odraslih črevesnih nematodov (Ancylostoma tubaeforme)
Treatment of adult intestinal roundworms (Toxocara canis)
Psi: ▪ zatiranje infestacij z ušmi (Trichodectes canis) ▪ zatiranje garij vrste Sarcoptes (Sarcoptes. scabiei). ▪ zatiranje odraslih črevesnih nematodov (Toxocara canis).
Use of the product in cats has on rare occasions been associated with a mild transient alopecia at the site of application.
Uporaba zdravila pri mačkah je bila v posameznih primerih povezana z rahlim in prehodnim izpadanjem dlake na mestu nanosa.
40 It is important to apply the dose as indicated to minimise the quantity that the animal can lick off.
Pomembno je, da odmerek nanesemo točno po navodilih; tako količino, ki bi jo žival lahko polizala, kar najbolj zmanjšamo.
STRONGHOLD has been tested with no other adverse reactions in over 100 different pure and mixed breeds of dogs including collies, and in mixed breeds and 16 pure breeds of cats.
Ostale informacije STRONGHOLD so testirali pri več kot 100 različnih čistih pasmah psov, vključno s koliji, in pri mešanih pasmah ter 16 čistih pasmah mačk in niso odkrili nobenih drugih stranskih učinkov.
The product was administered at 10 times the recommended dose, and no undesirable effects were observed.
Pri dajanju desetkratnega priporočenega odmerka niso opazili nobenih neželenih učinkov.
The product was administered at 3 times the recommended dose to cats and dogs infected with adult heartworms and no undesirable effects were observed.
Po trikratnem priporočenem odmerku, ki so ga dajali mačkam in psom, inficiranim z odraslimi filarijami, niso opazili neželenih učinkov.
In extensive field testing no interactions between the product and routinely used veterinary medicinal products or medical or surgical procedures were observed.
39 Pri testiranju na terenu niso opazili nikakršnega medsebojnega delovanja med STRONGHOLDOM in drugimi rutinsko uporabljenimi zdravili.
STRONGHOLD 15 mg: cats and dogs weighing 2.5 kg or less STRONGHOLD 30 mg: dogs weighing 2.6 kg - 5.0 kg STRONGHOLD 45 mg: cats weighing 2.6 kg - 7.5 kg STRONGHOLD 60 mg: dogs weighing 5.1 kg - 10.0 kg STRONGHOLD 120 mg: dogs weighing 10.1 kg - 20.0 kg STRONGHOLD 240 mg: dogs weighing 20.1 kg - 40.0kg
STRONGHOLD 240 mg: za pse s telesno maso 20, 1 do 40, 0 kg.
Administer STRONGHOLD topically in accordance with the following table:
Odmerke določimo po naslednji tabeli:
Tube cap colour
Barva tubinega pokrovčka
≤ 2.5 2.6-7.5 > 7.5
< 2, 5
Rose Blue
roza
0.25 0.75 Appropriate combination of tubes
ustrezna kombinacija
Tube cap colour
Barva tubinega pokrovačka
≤ 2.5 2.6-5.0 5.1-10.0 10.1-20.0 20.1-40.0 > 40
2, 6 – 5, 0 5, 1 – 10, 0
Rose Violet Brown Red Green
vijolična rjava
15 30 60 120 240 Appropriate combination of tubes
120
60 120 120 120 120 60/ 120
60/ 120
0.25 0.25 0.5 1.0 2.0 Appropriate combination of tubes
ustrezna kombinacija
41 Flea treatment and prevention (cats and dogs)
Zdravljenje in preprečevanje infestacije z bolhami (mačke in psi)
Animals older than six weeks of age:
● živali starejše od 6 tednov:
Following administration of the product to the animal, adult fleas and larvae are killed and no viable eggs are produced.
Po dajanju zdravila živalim odrasle bolhe in ličinke odmrejo in ni več jajčec, sposobnih za življenje.
This stops flea reproduction and may aid in the control of existing environmental flea infestations in areas to which the animal has access.
Na ta način se razmnoževanje bolh ustavi in lahko pomaga pri kontroli infestacije okolja z bolhami na področjih, ki so dostopna živalim..
For the prevention of flea infestations, the product should be administered to the animal at monthly intervals throughout the flea season, starting one month before fleas become active.
V sezoni razmnoževanja bolh je treba za preprečevanje infestacij z njimi zdravilo dajati v mesečnih presledkih, in sicer en mesec dni preden bolhe postanejo aktivne.
For use as part of a treatment strategy for flea allergy dermatitis the product should be administered at monthly intervals.
40 Zdravilo uspešno uporabljamo tudi za preprečevanje in zdravljenje alergijskega dermatitisa, ki ga povzročajo bolhe in sicer ga dajemo enkrat mesečno en odmerek.
Treatment of pregnant and lactating animals to prevent flea infestations in puppies and kittens:
● Zdravljenje brejih in doječih živali kot preventiva infestacij pri mladičkih psov in mačk
The product may be administered year-round or at least within one month of the animal’ s first exposure to mosquitoes and monthly thereafter until the end of the mosquito season.
Zdravilo lahko dajemo vse leto ali vsaj v enem mesecu po prvi izpostavitvi živali komarjem, nato pa vsak mesec, dokler traja njihova sezona.
When replacing another heartworm preventive product in a heartworm disease prevention programme, the first dose of the product must be given within a month of the last dose of the former medication.
Prvi odmerek damo v enem mesecu po zadnjem dajanju prejšnjega zdravila.
42 Treatment of sarcoptic mange (dogs)
Zatiranje garij vrste Sarcoptes (pri psih)
STRONGHOLD should be administered as a single topical application of a unit dose delivering a minimum of 6 mg/ kg selamectin.
STRONGHOLD nanašamo na kožo na predel zatilja (pred lopatici), v enkratnem odmerku 6 mg selamektina na kg telesne mase.
When concurrent infestations or infections in the same animal are to be treated with the product, only one topical application of the recommended 6 mg/ kg dose should be administered at any one time.
Kadar je treba zdraviti hkratne infestacije ali infekcije pri isti živali, dajemo naenkrat le priporočen odmerek 6 mg/ kg.
The appropriate length of the treatment period for individual parasites is specified in section DOSAGE FOR EACH SPECIES.
Ustrezen čas zdravljenja za posamezne parazite je naveden v poglavju Odmerki.
Do not apply when the hair coat is wet.
Zdravila ne nanašamo na mokro dlako.
Store in the unopened foil package in a dry place.
Vsebnik shranjujte v zaprti foliji, v suhem prostoru.
For ear mite treatment, do not apply directly to the ear canal.
42 Za zdravljenje ušesnih garij zdravila ne nanašamo neposredno v ušesni kanal.
Do not allow treated animals to bathe in water courses until at least two hours after treatment.
Zdravljene živali se najmanj dve uri po zdravljenju ne smejo kopati v tekočih vodah.
If accidental eye exposure occurs, flush the eyes immediately with water and seek medical attention.
Če pride zdravilo pomotama v oči, jih je treba takoj izpirati z obilo vode in poiskati zdravniško pomoč.
Highly Flammable; keep away from heat, sparks, open flame or other sources of ignition.
Izdelek je lahko vnetljiv, zato ga hranite zaščitenega pred vročino, iskrami, odprtim plamenom ali drugimi vnetljivimi viri.
STRONGHOLD is available in packs of three tubes (for all tube sizes), six tubes (for all tube sizes except 15 mg selamectin), or fifteen tubes (for 15 mg selamectin tube size only).
Stronghold se nahaja v ovojnini s tremi tubami (vse velikosti tub), s šestimi tubami (vse velikosti tub razen Stronghold 15 mg), ali v ovojnini s petnajstimi tubami (samo tuba s 15 mg selamektina).
Č eská republika Pfizer Animal Health Tel: +420 283 004 111
43 Česká republika Pfizer Animal Health Tel: +420 283 004 111
Suprelorin is used for male dogs to make them temporarily infertile.
Zdravilo Suprelorin se uporablja pri psih samcih za povzročitev začasne neplodnosti.
It is used in healthy, sexually- mature dogs that have not been neutered.
Uporablja se pri zdravih, spolno zrelih, neskopljenih psih.
The implant is inserted subcutaneously, under the loose skin on the back between the lower neck and the lumbar area.
Implantat se aplicira subkutano, pod ohlapno kožo na hrbtu med spodnjim delom vratu in ledvenim predelom.
Suprelorin starts being effective after about six weeks, and the effect continues for six months, after which the dog can be re-implanted if necessary.
Zdravilo Suprelorin začne učinkovati po približno šestih tednih, učinek pa traja šest mesecev; zatem je mogoče psu implantat po potrebi ponovno vbrizgati.
Effectiveness is immediate if re-implanted approximately 6 months following previous implantation.
Učinek je takojšen, če se ponovna implanatacija izvede približno 6 mesecev po predhodni.
The active substance in Suprelorin, deslorelin, acts like the natural hormone gonadotropin-releasing hormone (GnRH) which controls the secretion of other hormones involved in fertility.
Zdravilna učinkovina zdravila Suprelorin, deslorelin, deluje kot naravni hormon gonadotropin sproščujoči hormon (GnRH), ki uravnava izločanje drugih hormonov, ki sodelujejo pri zagotavljanju plodnosti.
As a result in male dogs, less testosterone circulates in the blood, the dog stops producing sperm and its libido is reduced.
Posledično je v krvnem obtoku psov samcev manj testosterona, pes preneha proizvajati spermo, njegov libido pa se zmanjša.
If a dog under treatment with Suprelorin were to mate with a bitch on heat, the chance of the bitch becoming pregnant would be extremely low.
Če bi se pes, ki je dobil zdravilo Suprelorin, sparil s samico, ki se goni, bi bila verjetnost brejosti izjemno nizka.
Suprelorin has been studied under field conditions in dogs weighing between 10 and 25 kg which were implanted before being followed up for up to a year.
Zdravilo Suprelorin so preučevali v pogojih na terenu pri psih, ki so tehtali med 10 in 25 kg ter so jih po implantaciji spremljali do eno leto.
The studies looked at the effect of Suprelorin on blood testosterone levels, the size of the testicles and the ability of the dogs to produce semen for collection.
V študijah so preučevali učinek zdravila Suprelorin na raven testosterona v krvi, na velikost mod in sposobnost psov, da proizvajajo seme za zbiranje.
In some of these studies, the dogs received Suprelorin more than once and were observed for up to a year after receiving the final implant.
V nekaterih izmed teh študij so psi prejeli zdravilo Suprelorin več kot enkrat in so bili opazovani do eno leto po prejemu zadnjega implantata.
The safety of Suprelorin was studied after giving dogs more than 10 times the recommended dose rate.
Varnost zdravila Suprelorin je bila preučevana potem, ko so psi prejeli zdravilo v odmerku, ki je več kot 10- krat večji od priporočenega.
What benefit has Suprelorin shown during the studies?
Kakšne koristi je zdravilo Suprelorin izkazalo med raziskavami?
All studies showed a reduction of testosterone levels in the blood, a reduction in the size of the testicles, decreased libido and decreased spermatogenesis (when fewer sperms are produced by the 7 Westferry Circus, Canary Wharf, London E14 4HB, UK Tel.
Pri večini psov so se 7 Westferry Circus, Canary Wharf, London E14 4HB, UK Tel.
The majority of dogs regained normal semen characteristics approximately one year after the last treatment and dogs have been able to successfully mate with bitches, after treatment with Suprelorin was stopped.
(44- 20) 74 18 84 00 Fax (44- 20) 74 18 84 47 E- mail: mail@ emea. europa. eu http: // www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged normalne značilnosti semena povrnile po približno enem letu od zadnjega zdravljenja, psi pa so se po prenehanju zdravljenja z zdravilom Suprelorin lahko uspešno sparili s samicami.
There can also some be some local reaction (e. g. inflammation, hardening) for up to three months after implantation.
Možne so tudi lokalne reakcije (npr. vnetje, zatrdlina) do tri mesece po implantaciji.
The size of the testicles will decrease during treatment.
Velikost mod se med zdravljenjem zmanjša.
Suprelorin is not recommended for use in dogs that have not yet reached puberty, as it has not been investigated in these animals.
Zdravila Suprelorin ni priporočljivo uporabljati pri psih, ki še niso dosegli pubertete, saj pri teh živalih ni bilo preučevano.
For a full list of all side effects reported with Suprelorin, see the Package Leaflet.
Za celoten seznam neželenih učinkov, o katerih so poročali pri uporabi zdravila Suprelorin, glejte Navodilo za uporabo.
In case of accidental self-injection, medical advice should be sought immediately and the Package Leaflet or the label shown to the doctor.
V primeru nenamernega samoinjiciranja takoj poiščite zdravniško pomoč in zdravniku pokažite Navodilo za uporabo ali nalepko.
The Committee for Medicinal Products for Veterinary Use (CVMP) concluded that the benefits of Suprelorin outweigh its risks for the induction of temporary infertility in healthy, entire, sexually mature male dogs and recommended that Suprelorin be given a marketing authorisation.
Odbor za zdravila za uporabo v veterinarski medicini (CVMP) je sklenil, da so koristi zdravila Suprelorin za zagotavljanje začasne neplodnosti pri zdravih, neskopljenih, spolno zrelih psih samcih večje od z njim povezanih tveganj, zato je priporočil, da se za zdravilo Suprelorin odobri dovoljenje za promet.
The European Commission granted a marketing authorisation valid throughout the European Union, for Suprelorin to Cyton Biosciences on 10/ 07/ 2007.
Evropska komisija je dovoljenje za promet z zdravilom Suprelorin, veljavno po vsej Evropski uniji, odobrila družbi Cyton Biosciences dne 10/ 07/ 2007.
This summary was last updated in July 2007.
Povzetek je bil nazadnje posodobljen julija 2007.
Sealed foil pouch in cardboard carton
Neprodušno zaprta vrečka iz folije v kartonasti škatli
2 implants preloaded in implanters + 1 actuator
2 implantata 2 implantata, napolnjena v implantatorja + 1 aktivator
5 implants preloaded in implanters + 1 actuator
5 implantatov 5 implantatov, napolnjenih v implantatorje + 1 aktivator
Suprelorin 4.7 mg implant for dogs
Suprelorin 4, 7 mg implantat za pse
4.7 mg deslorelin (as deslorelin acetate)
4, 7 mg deslorelina (v obliki deslorelinijevega acetata)
Implant White to pale yellow cylindrical implant.
Implantat Bel do svetlo rumen valjast implantat.
Dogs (Male).
Psi (samci).
Treated dogs should therefore still be kept away from bitches on heat within the first six weeks after initial treatment.
Zato moramo pse, ki so prejeli implantat, prvih šest tednov po začetni uporabi še vedno imeti ločene od psic, ki se gonijo.
One out of 75 dogs treated with the product during clinical trials mated and tied with a bitch on heat within six months of implantation, but this did not result in pregnancy.
Eden od 75 psov, ki so v kliničnih preskusih prejeli implantat, se je v šestih mesecih po implantaciji uspešno sparil s psico, ki se je gonila, vendar temu ni sledila brejost.
Should a treated dog mate with a bitch between six weeks and six months after treatment, appropriate measures should be taken to rule out the risk of pregnancy.
Če se pes, ki je dobil implantat, spari s samico v času od šest tednov do šest mesecev po implantaciji, je treba z ustreznimi ukrepi izključiti tveganje brejosti.
Any mating that occurs more than six months after the administration of the product may result in pregnancy.
Vsako parjenje, do katerega pride več kot šest mesecev po uporabi zdravila, lahko povzroči brejost.
However, it is not necessary to keep bitches away from treated dogs following subsequent implantations, provided that the product is administered every six months.
Pod pogojem, da se zdravilo uporabi vsakih šest mesecev, po poznejših implantacijah psic ni treba več ločevati od tretiranih psov.
The ability of dogs to sire offspring following their return to normal plasma testosterone levels, after the administration of the product, has not been investigated.
Sposobnosti psov, da zaplodijo potomstvo, potem ko se jim po uporabi zdravila plazemska koncentracija testosterona vrne na normalno vrednost, niso raziskovali.
2 With respect to testosterone levels (an established surrogate marker of fertility), during clinical trials more than 80% of dogs administered one or more implants, returned to normal plasma testosterone levels (≥ 0.4 ng/ ml) within 12 months of implantation.
Pri 98 odstotkih psov so se plazemske
Ninety-eight percent of dogs returned to normal plasma testosterone levels within 18 months of implantation.
2 koncentracije testosterona v 18 mesecih po implantaciji vrnile na normalne vrednosti.
However, data demonstrating the complete reversibility of clinical effects (reduced testicular size, reduced ejaculation volume, reduced sperm count and reduced libido) including fertility after six months, or repeated implantation, are limited.
Vendar so podatki, ki kažejo popolno reverzibilnost kliničnih učinkov (zmanjšana moda, zmanjšana količina ejakulata, zmanjšano število semenčic in zmanjšan libido), s plodnostjo vred, po šestih mesecih ali večkratnih implantacijah, omejeni.
During clinical trials, most of the smaller size dogs (< 10 kg) maintained suppressed levels of testosterone for more than 12 months following implantation.
Med kliničnimi preskusi so se pri večini manjših psov (< 10 kg) vzdrževale znižane koncentracije testosterona več kot 12 mesecev po implantaciji.
For very large dogs (> 40 kg), data are limited but duration of testosterone suppression was comparable to that seen in medium and large dogs.
Za zelo velike pse (> 40 kg) so podatki omejeni, vendar je bilo trajanje supresije testosterona primerljivo s trajanjem, ugotovljenim pri srednjih in velikih psih.
The use of the product in dogs of less than 10 kg or more than 40 kg bodyweight, therefore, should be subject to a risk/ benefit assessment performed by the veterinarian.
Pri uporabi zdravila pri psih s telesno težo, manjšo od 10 kg ali večjo od 40 kg, je zato potrebna ocena razmerja med tveganjem in koristjo, ki jo opravi veterinar.
The use of the product in pre-pubertal dogs has not been investigated.
Uporabe tega zdravila pri psih pred puberteto niso raziskali.
It is therefore recommended that dogs should be allowed to reach puberty before treatment with the product is initiated.
Zato priporočamo, naj pred začetkom uporabe zdravila psi dosežejo puberteto.
Data demonstrate that treatment with the product will reduce the libido of the dog, but other behavioural changes (e. g. male-associated aggression) have not been investigated.
Podatki kažejo, da bo dajanje zdravila zmanjšalo libido psa, niso pa raziskovali drugih vedenjskih sprememb (n. pr. agresivnosti, povezane s samci).
Although skin contact with the product is unlikely, should this occur, wash the exposed area immediately, as GnRH analogues may be absorbed through the skin.
Čeprav stik kože z zdravilom ni verjeten, je treba, če do njega pride, nemudoma sprati izpostavljeni predel, ker se analogi GnRH lahko absorbirajo skozi kožo.
When administering the product, take care to avoid accidental self-injection by ensuring that animals are suitably restrained and the application needle is shielded until the moment of implantation.
Pri dajanju zdravila pazite, da bodo živali primerno imobilizirane in da bo igla za dajanje zdravila zaščitena s pokrovčkom vse do trenutka implantacije, da si zdravila ne bi nehote samoinjicirali.
A significant decrease in testicle size will be seen during the treatment period.
Med obdobjem učinkovanja zdravila ugotavljamo znatno zmanjšanje mod.
3 4.8 Interaction with other medicinal products and other forms of interaction
4. 8 Medsebojno delovanje z drugimi zdravili in druge oblike interakcij
4.9 Amounts to be administered and administration route
3 4. 9 Odmerjanje in pot uporabe
The product should be implanted subcutaneously in the loose skin on the back between the lower neck and the lumbar area.
Izdelek implantirajte subkutano v ohlapno kožo na hrbtu med spodnjim delom vratu in ledvenim predelom.
Repeat administration every six months to maintain efficacy.
Zdravilo dajte vsakih šest mesecev, da se bo učinkovitost vzdrževala.